Brainsway Ltd. (BWAY) stock
BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
$9.39−0.72 (-7.12%)
Close on Nov 16, 2026Market cap $367.77MP/E 52.2Yield –
Brainsway r&d expenses
Research and development expenses are spending on new products and technology.
Brainsway's R&D Expenses for the twelve months ending Dec 31, 2020 was $5.82M, down 26.1% year over year. For fiscal 2025 it was $9.60M, up 33.6% from the year before. The highest annual figure on record is $9.60M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.60M | +33.6% |
| FY2024 | Dec 31, 2024 | $7.19M | +7.9% |
| FY2023 | Dec 31, 2023 | $6.67M | -13.2% |
| FY2022 | Dec 31, 2022 | $7.68M | +20.1% |
| FY2021 | Dec 31, 2021 | $6.39M | +9.8% |
| FY2020 | Dec 31, 2020 | $5.82M | -26.1% |
| FY2019 | Dec 31, 2019 | $7.88M | +27.9% |
| FY2018 | Dec 31, 2018 | $6.16M | +15.2% |
| FY2017 | Dec 31, 2017 | $5.34M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | $1.58M | – |
| Q4 FY2019 | Dec 31, 2019 | $1.81M | – |
See a number that looks wrong?